ProFunds Biotechnology UltraSector Fund Investor Class BIPIX:NASDAQ

Net Asset Value$59.23Closing Price - 11/16/2018
1-Day Change+0.57(0.97%)
YTD Change-3.24(5.19%)

Growth of $10,000 Since Fund Inception

View portfolioPortfolio as of 07/31/2018

Top 5 SectorsTop 5 Holdings
Health Technology73.40%
AbbVie Inc ORD12.40%
Health Services1.99%
Amgen Inc ORD11.62%
Commercial Services1.00%
Gilead Sciences Inc ORD8.98%
  
Biogen Inc ORD6.26%
  
Celgene Corp ORD5.65%
Concentration of Top 576.39% Concentration of Top 544.91% 

Fund Profile

Fund Strategy

The Fund seeks daily investment results, before fees and expenses, that correspond to 150% of the performance of the Dow Jones U.S. Biotechnology Index.

Fund Category Sector Equity
Inception Date 06/19/2000
Manager Neches/Lowery
Fund Classification Equity Leverage Funds
Managed Since 2013
Other Managed Funds   INPIX  CYPIX  HCPIX  TEPIX  SMPIX

Lipper Leader Scorecard as of 10/31/2018

RatingTotal
Return
Consistent
Return
PreservationTax
Efficiency
Expense*
Overall Rating(# of funds in category)
182

178

12,147

182

41
3 Year Rating(# of funds in category)
182

180

12,147

182

41
5 Year Rating(# of funds in category)
155

153

10,247

155

40
10 Year Rating(# of funds in category)
107

107

6,932

107

39

Fund Highlights

Total Expense Ratio1.43%
Average Market Capitallization$74.7 B
Net Asset ValueN/A
Total Net Assets$201.3 M
Sales ExpensesNo Load Fund
Minimum Initial Investment$15000
Minimum IRA Investment$15000
AvailabilityOpen to New Investors
Current Yield0.00%
Dividend Ex-DateN/A

Risk Analysis

Beta vs. S&P 5002.44
R-Squared vs. S&P 5000.52
Standard Deviation29.66%
Sharpe Ratio0.45
Portfolio TurnoverN/A